Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ironwood Pharmaceuticals EBITDA Margin 2010-2023 | IRWD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ironwood Pharmaceuticals (IRWD) over the last 10 years. The current EBITDA margin for Ironwood Pharmaceuticals as of December 31, 2023 is .
  
Ironwood Pharmaceuticals EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $0.44B $-0.94B -213.09%
2023-09-30 $0.43B $-0.91B -211.34%
2023-06-30 $0.43B $-0.89B -207.26%
2023-03-31 $0.42B $0.25B 60.91%
2022-12-31 $0.41B $0.25B 61.31%
2022-09-30 $0.42B $0.24B 57.01%
2022-06-30 $0.42B $0.24B 56.97%
2022-03-31 $0.42B $0.25B 58.16%
2021-12-31 $0.41B $0.23B 56.52%
2021-09-30 $0.41B $0.23B 55.31%
2021-06-30 $0.41B $0.21B 50.85%
2021-03-31 $0.40B $0.18B 44.72%
2020-12-31 $0.39B $0.15B 37.53%
2020-09-30 $0.40B $0.14B 36.18%
2020-06-30 $0.43B $0.17B 38.97%
2020-03-31 $0.44B $0.16B 35.31%
2019-12-31 $0.43B $0.13B 29.21%
2019-09-30 $0.43B $0.12B 28.18%
2019-06-30 $0.37B $-0.09B -24.73%
2019-03-31 $0.35B $-0.12B -35.73%
2018-12-31 $0.35B $-0.14B -40.06%
2018-09-30 $0.31B $-0.10B -31.61%
2018-06-30 $0.33B $0.03B 9.06%
2018-03-31 $0.32B $0.00B 0.63%
2017-12-31 $0.30B $-0.00B -1.01%
2017-09-30 $0.29B $-0.10B -33.68%
2017-06-30 $0.27B $-0.11B -38.89%
2017-03-31 $0.26B $-0.08B -30.12%
2016-12-31 $0.27B $-0.04B -15.02%
2016-09-30 $0.24B $-0.04B -15.48%
2016-06-30 $0.21B $-0.04B -17.37%
2016-03-31 $0.19B $-0.06B -34.22%
2015-12-31 $0.15B $-0.09B -60.00%
2015-09-30 $0.14B $-0.12B -86.67%
2015-06-30 $0.11B $-0.13B -114.29%
2015-03-31 $0.09B $-0.14B -154.95%
2014-12-31 $0.08B $-0.16B -203.90%
2014-09-30 $0.04B $-0.17B -388.64%
2014-06-30 $0.03B $-0.19B -593.75%
2014-03-31 $0.04B $-0.20B -557.14%
2013-12-31 $0.02B $-0.24B -1043.48%
2013-09-30 $0.05B $-0.24B -526.67%
2013-06-30 $0.14B $-0.13B -97.79%
2013-03-31 $0.14B $-0.11B -80.85%
2012-12-31 $0.15B $-0.06B -40.67%
2012-09-30 $0.16B $-0.02B -15.48%
2012-06-30 $0.07B $-0.09B -132.39%
2012-03-31 $0.07B $-0.07B -107.46%
2011-12-31 $0.07B $-0.06B -84.62%
2011-09-30 $0.05B $-0.06B -124.00%
2011-06-30 $0.05B $-0.06B -123.40%
2011-03-31 $0.05B $-0.06B -128.89%
2010-12-31 $0.04B $-0.06B -125.00%
2010-09-30 $0.03B $-0.06B -170.59%
2010-06-30 $0.04B $-0.05B -125.00%
2010-03-31 $0.04B $-0.05B -134.21%
2009-12-31 $0.03B $-0.06B -161.76%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.262B $0.443B
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic constipation. Ironwood and AbbVie co-develop & co-commercialize Linzess in all other territories world wide. Linzess is marketed by Allergan for IBS-C in Europe and Canada under the brand name Constella. The company receives royalties on sales of Constella in Europe and Canada from AbbVie. In Japan, it has partnered with Astellas Pharma for the development and commercialization of Linzess and with AstraZeneca in China, Hong Kong & Macau. Linzess received approval for IBS-C indication in Japan for chronic constipation and in China for IBS-C. The company completed the spin-off of its soluble guanylate cyclase segment into a separate, publicly traded company, Cyclerion Therapeutics.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.564B 27.36
Chugai Pharmaceutical (CHGCY) Japan $54.745B 23.77
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.246B 24.44
Sandoz Group AG (SDZNY) Switzerland $14.663B 0.00
Shionogi (SGIOY) Japan $14.423B 12.48
Neurocrine Biosciences (NBIX) United States $13.300B 55.23
United Therapeutics (UTHR) United States $11.015B 11.80
Catalent (CTLT) United States $10.144B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.644B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.856B 6.95
Revolution Medicines (RVMD) United States $6.000B 0.00
Ionis Pharmaceuticals (IONS) United States $5.986B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.248B 0.00
Alpine Immune Sciences (ALPN) United States $4.233B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.023B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.964B 0.00
Evotec AG (EVO) Germany $2.608B 0.00
Indivior (INDV) United States $2.556B 11.89
Summit Therapeutics (SMMT) United States $2.449B 0.00
Corcept Therapeutics (CORT) United States $2.321B 23.47
Dyne Therapeutics (DYN) United States $2.143B 0.00
PTC Therapeutics (PTCT) United States $1.990B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.809B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.806B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.783B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.782B 18.42
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.649B 9.76
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.567B 0.00
Ardelyx (ARDX) United States $1.515B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Soleno Therapeutics (SLNO) United States $1.219B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Collegium Pharmaceutical (COLL) United States $1.136B 6.99
Xencor (XNCR) United States $1.113B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.003B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.909B 0.00
Cronos Group (CRON) Canada $0.902B 0.00
Cassava Sciences (SAVA) United States $0.887B 0.00
USANA Health Sciences (USNA) United States $0.851B 13.40
Enliven Therapeutics (ELVN) United States $0.825B 0.00
ARS Pharmaceuticals (SPRY) United States $0.792B 0.00
Ocular Therapeutix (OCUL) United States $0.785B 0.00
Relay Therapeutics (RLAY) United States $0.781B 0.00
Sage Therapeutics (SAGE) United States $0.775B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.730B 0.00
Silence Therapeutics (SLN) United Kingdom $0.673B 0.00
Savara (SVRA) United States $0.649B 0.00
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Siga Technologies (SIGA) United States $0.594B 8.79
Verve Therapeutics (VERV) United States $0.578B 0.00
Korro Bio (KRRO) United States $0.549B 0.00
OmniAb (OABI) United States $0.548B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.539B 0.00
Altimmune (ALT) United States $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.483B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.417B 0.00
Larimar Therapeutics (LRMR) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.392B 74.25
Heron Therapeutics (HRTX) United States $0.389B 0.00
Harrow (HROW) United States $0.375B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.43
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Bioventus (BVS) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Fractyl Health (GUTS) United States $0.313B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.284B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Nanobiotix S.A (NBTX) France $0.270B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Black Diamond Therapeutics (BDTX) United States $0.260B 0.00
Adherex Technologies (FENC) United States $0.254B 0.00
Metagenomi (MGX) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Foghorn Therapeutics (FHTX) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.211B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.198B 0.00
Century Therapeutics (IPSC) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Galectin Therapeutics (GALT) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.149B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.144B 0.00
Elite Pharmaceuticals (ELTP) United States $0.136B 12.72
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Relmada Therapeutics (RLMD) United States $0.117B 0.00
OptiNose (OPTN) United States $0.116B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
Inotiv (NOTV) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.089B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Carisma Therapeutics (CARM) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.80
MEI Pharma (MEIP) United States $0.022B 1.13
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.81